This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Investors Shun Bed Bath & Beyond, Walgreens Growth Deals

NEW YORK (TheStreet) -- After growing earnings from post-recession lows, companies like Bed Bath & Beyond (BBBY) and Walgreens (WAG) have recently cut their biggest ever acquisitions in an effort to retool earnings prospects and growth.

The problem is that in a lukewarm earnings environment, investors have punished both companies - in part - for the moves. Now, it's time for investors to question whether widespread corporate austerity can be a long-term opportunity for the companies that are mapping out new growth plans.

In May, Bed Bath & Beyond (BBBY) cut its biggest-ever acquisition when it bought Cost Plus World Market (CPWM) for nearly $500 million, in a deal that was seen as a way to combat a slowdown at the brick-and-mortar home goods store. Initially, the move pushed Bed Bath & Beyond to all-time highs over $75 a share as many perceived the deal to be a smart growth play.

After announcing a second quarter sales and profit margin slowdown on Wednesday and providing a cloudy outlook for the remainder of 2012, investors are punishing Bed Bath & Beyond shares, pushing them nearly 15% lower to $62.96 in Thursday trading, erasing share gains since the Cost Plus deal. But faced with less-than-stellar comparable store sales and earnings, the strategic benefits of the acquisition may be all the more clear.

Many analysts reacted to the Union, N.J.-based retailers share slump as overdone, citing high expectations for Bed Bath & Beyond's M&A and continued strong execution by management. Credit Suisse analyst Gary Balter, who raised his Bed Bath & Beyond price target to $91 after the Cost Plus acquisition, said there was "little to like" in the company's earnings and guidance. When pressed to decide whether the earnings show growth has peaked at Bed Bath & Beyond or if the company's M&A will revive sales, Balter remains a bull.

"We believe investors are overreacting to the costs of the acquisitions and underestimating the benefits," wrote Balter in a note reacting to earnings. "We are especially excited by the Cost Plus acquisition, which we believe can provide significant sourcing and comp opportunities in the future," he added, noting that part of Bed Bath & Beyond's guidance miss comes from costs associated with the acquisition that should have been expected.

After successfully competing with the likes of Web-based competitor Amazon (AMZN)and big box retailers, acquiring new channels of growth may not be such a bad bet for Bed Bath & Beyond, after posting a 30%-plus three year growth rate of earnings.

Stock quotes in this article: BBBY, WAG, CPWM, CVS, ESRX 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs